StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

BNTCBullishAnalyst Target Updateanalyst
Medium materiality6/10

Wedbush Raises Benitec BioPharma (BNTC) Price Target to $20

Nov 16, 2026, 11:05 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Bullish analyst update, tempered by the uncertainty of a single price target and the company's biotech exposure.

AI summary

What happened, with direct paths to the underlying reporting

Wedbush raised its price target on BNTC to $20; the posted price was $9.04. The update is bullish, though an analyst target is an opinion and does not establish likely performance.

  • Wedbush raised BNTC's price target to $20.
  • Posted price: $9.04.

Key facts

  1. 01

    Target: $20

  2. 02

    Posted price: $9.04

  3. 03

    Analyst firm: Wedbush

  4. 04

    Analyst: Yun Zhong

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.